You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stemline

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Selinexor in Relapsed or Refractory Multiple Myeloma - SEATTLE-

Recruiting
  • Multiple Myeloma
  • Wien, Austria
  • +1 more
Jul 13, 2023

Acute Myeloid Leukemia Trial (Tagraxofusp (Cycles 1-2), Azacitidine, Tagraxofusp (Cycles 3-12))

Not yet recruiting
  • Acute Myeloid Leukemia
  • Tagraxofusp (Cycles 1-2)
  • +2 more
  • (no location specified)
Jun 28, 2022

Acute Myeloid Leukemia Trial in Los Angeles, San Francisco (Azacitidine, Tagraxofusp-erzs)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +1 more
Jan 31, 2023

Hepatic Impairment Trial (Elacestrant diHCl)

Not yet recruiting
  • Hepatic Impairment
  • Elacestrant dihydrochloride
  • (no location specified)
Nov 6, 2023

Breast Tumors, Brain Tumors, Tumors by Site Trial (Abemaciclib, Elacestrant)

Recruiting
  • Breast Neoplasms
  • +7 more
  • Canton, Ohio
    Gabrail Cancer Center
Jan 24, 2023

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Breast Cancer, Metastatic Breast Cancer Trial (Elacestrant, Alpelisib, Everolimus)

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • (no location specified)
Sep 28, 2022

Advanced Solid Tumor Trial in Sutton, Manchester (SL-901)

Recruiting
  • Advanced Solid Tumor
  • Sutton, Surrey, United Kingdom
  • +1 more
May 16, 2022

Metastatic Breast Cancer Trial (Elacestrant)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 24, 2022

Metastatic Breast Cancer Trial in Belgium, Netherlands (RAD1901)

Completed
  • Metastatic Breast Cancer
  • Bruxelles, Belgium
  • +4 more
Aug 16, 2022

Hormone Receptor Positive Malignant Tumor of Breast Trial in United States (RAD140)

Completed
  • Hormone Receptor Positive Malignant Neoplasm of Breast
  • New Haven, Connecticut
  • +4 more
Aug 16, 2022

Advanced ER+, HER2-Negative Breast Cancer Trial in Waltham (Elacestrant)

Completed
  • Advanced ER+, HER2-Negative Breast Cancer
  • Waltham, Massachusetts
    Radius Pharmaceuticals, Inc.
Aug 16, 2022

Acute Myeloid Leukemia Trial in United States (SL-401)

Terminated
  • Acute Myeloid Leukemia
  • Tampa, Florida
  • +6 more
Jan 13, 2022

Solid Tumors Trial in United States (SL-801)

Terminated
  • Solid Tumors
  • New Haven, Connecticut
  • +5 more
Jan 27, 2022

Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)

Active, not recruiting
  • Breast Cancer
  • Tucson, Arizona
  • +167 more
Jul 19, 2022

Acute Myeloid Leukemia Trial in Baltimore (Dose Escalation -tagraxofusp-erzs, Dose Expansion at RP2D -tagraxofusp-erzs)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Dose Escalation -tagraxofusp-erzs
  • Dose Expansion at RP2D -tagraxofusp-erzs
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 27, 2023

Multiple Myeloma Trial in Duarte, Boston, Portland (SL-401/ Pomalidomide/ Dexamethasone)

Terminated
  • Multiple Myeloma
  • SL-401/ Pomalidomide/ Dexamethasone
  • Duarte, California
  • +2 more
Jan 13, 2022

Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Acute Myeloid Leukemia Trial in United States (SL-401)

Completed
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
  • Acute Myeloid Leukemia
  • Duarte, California
  • +8 more
Apr 6, 2020

Adult Brain Glioblastoma, Glioblastoma Multiforme Trial in United States (SL-701; poly-ICLC (polyinosinic-polycytidylic acid

Completed
  • Adult Brain Glioblastoma
  • Glioblastoma Multiforme
  • SL-701; poly-ICLC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethyl cellulose)
  • Bevacizumab
  • Birmingham, Alabama
  • +15 more
Jan 24, 2018